Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uveal Melanoma × Azacitidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 378 Myelodysplastic Syndromes 160 Leukemia, Myelomonocytic, Chronic 76 Leukemia 65 Recurrence 32 Myeloproliferative Disorders 23 Hematologic Neoplasms 20 Neoplasms 19 Multiple Myeloma 17 Carcinoma, Non-Small-Cell Lung 17 Lymphoma, Non-Hodgkin 16 Lymphoma 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Lymphoma, Large B-Cell, Diffuse 14 Anemia, Refractory, with Excess of Blasts 14 Lymphoma, T-Cell, Peripheral 13 Primary Myelofibrosis 12 Neoplasm, Residual 12 Leukemia, Monocytic, Acute 11 Leukemia, Lymphocytic, Chronic, B-Cell 11 Leukemia, Biphenotypic, Acute 11 Leukemia, Myelomonocytic, Acute 10 Hodgkin Disease 10 Myelodysplastic-Myeloproliferative Diseases 9 Leukemia, Erythroblastic, Acute 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Leukemia, Myeloid 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Leukemia, Megakaryoblastic, Acute 8 Congenital Abnormalities 8

Interventions

Ipilimumab 29 Nivolumab 23 pembrolizumab 14 incomplete Freund's adjuvant 10 Melphalan 9 Interleukin-2 9 Cyclophosphamide 9 CTLA-4 Antigen 8 tebentafusp 7 sargramostim 7 Temozolomide 7 MART-1 Antigen 7 Dacarbazine 7 Ranibizumab 6 montanide ISA 51 5 Sunitinib 5 Radiosurgery 5 Carboplatin 5 Blood Specimen Collection 5 Bevacizumab 5 fludarabine phosphate 4 fludarabine 4 aldesleukin 4 aflibercept 4 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Biopsy 4 trametinib 3 sotrastaurin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04729543 2023-12-04

MC2TCR

Erasmus Medical Center

Phase 1/2 Recruiting

DermatologicHead & Neck

Uveal Melanoma, Head and Neck Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡